N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.
Your search for smoking cessation returned 184 results
Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group.
High quality communication in tobacco treatment programs with lung cancer screenings was significantly associated with self-efficacy for smoking cessation.
Guideline offers simple practice changes that may increase effectiveness of tobacco-dependence pharmacotherapy.
One-year abstinence higher with e-cigarettes than other nicotine replacement products
The authors note that e-cigarettes seem to double the likelihood of achieving abstinence and are as effective as nicotine replacement therapy for supporting cessation.
No evidence that varenicline, bupropion, or nicotine replacement increase probability of abstinence
Overall, 22.7 percent received smoking cessation pharmacotherapy, most often the nicotine patch
Ninety-seven percent of smoking patients with MI received counseling, but few have SCM use